Entero Healthcare Solutions Limited has filed its quarterly compliance certificate with stock exchanges, fulfilling mandatory regulatory requirements under SEBI Depositories and Participants Regulations for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company submitted the certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, to both BSE Limited and National Stock Exchange of India Limited on April 8, 2026. The filing was signed by Sanu Kapoor, Vice President-General Counsel, Company Secretary & Compliance Officer.

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate on April 3, 2026. The registrar confirmed that securities received from depository participants for dematerialization during the quarter were properly processed within prescribed timelines.

Certificate Confirmation Details

The registrar's certificate confirms several key compliance aspects:

• Securities received for dematerialization were confirmed to depositories
• All security certificates were mutilated and cancelled after verification
• Depository names were substituted in the register of members as registered owners
• All processes were completed within prescribed regulatory timelines

Corporate Information

The certificate was signed by Ashok Shetty, Sr. Vice President-Corporate Registry at MUFG Intime India Private Limited. This quarterly filing demonstrates the company's ongoing compliance with SEBI regulations governing depositories and participant operations, ensuring proper handling of securities dematerialization processes.

Entero healthcare solutions Limited has announced the resignation of a key senior management personnel, marking a significant change in its leadership structure. The company disclosed this development to stock exchanges in compliance with regulatory requirements.

Senior Management Departure

Mr. Sambit Mohanty, who served as President – Institutional Business, has tendered his resignation from the company. His departure represents a change in the senior management team responsible for the company's institutional business operations.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was made through official communication to both BSE and NSE on March 11, 2026.

In his resignation letter, Mr. Mohanty expressed gratitude to the Board of Directors for their support and guidance during his tenure with the company. He specifically acknowledged the leadership team's contribution to his professional development.

Transition Details

The resignation follows standard corporate procedures, with the departing executive providing appropriate notice period. Mr. Mohanty will continue in his role until the close of business hours on March 31, 2026, ensuring a structured transition of responsibilities.

The company's disclosure indicates that this change in senior management personnel is part of normal corporate evolution, with the executive pursuing external career advancement opportunities. Entero Healthcare Solutions has completed all necessary regulatory filings regarding this leadership transition.